Ursodeoxycholic acid in the management of symptomatic gallstone disease: systematic review and clinician survey.

Lewis Hall,James Halle-Smith,Richard Evans,Giles Toogood,Tom Wiggins,Sheraz R Markar, Spyros Kapoulas, Paul Super,Olga Tucker,Siobhan C McKay

BJS open（2023）

引用 0|浏览11

暂无评分

摘要

Evidence for UDCA in symptomatic gallstones is scarce and heterogenous. Clinicians currently managing symptomatic gallstone disease are largely unaware of the benefit of UDCA, and there is clinical equipoise surrounding the benefit of UDCA. Level 1 evidence is required by clinicians to support UDCA use in the future.

查看译文

关键词

symptomatic gallstone disease,ursodeoxycholic acid

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要